JB
Joseph K Belanoff (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $3.2M of CORT (40,000 sh × $79.77, as filed), executed Dec 1 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.4M
shares × price, as filed
Last traded
Jun 1
Filed Jun 2
Median ADV $130.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $29.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
CORTRecent filings
CORTSALE
Corcept Therapeutics Incorporated
View filing →
$3.3M40,000 sh across 8 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $2.9M
40,000 sh across 2 lots
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $3.3M
35,102 sh × $94.72
Exec Mar 31 2025
Filed Apr 2 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $120K
1,974 sh × $60.83
Exec Mar 24 2025
Filed Mar 26 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $178K
2,924 sh × $60.91
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET